Loratadine-d5 |
An internal standard for the quantification of loratadine by GC- or LC-MS |
1 mg |
25040-1 |
More Info
|
Loratadine-d5 |
An internal standard for the quantification of loratadine by GC- or LC-MS |
5 mg |
25040-5 |
More Info
|
Loratadine-d5 |
An internal standard for the quantification of loratadine by GC- or LC-MS |
500 µg |
25040-500 |
More Info
|
Loratadine N-oxide |
A metabolite of loratadine |
1 mg |
35244-1 |
More Info
|
Loratadine N-oxide |
A metabolite of loratadine |
10 mg |
35244-10 |
More Info
|
Loratadine N-oxide |
A metabolite of loratadine |
5 mg |
35244-5 |
More Info
|
Lorazepam-d4 |
An internal standard for the quantification of lorazepam by GC- or LC-MS;… |
1 mg |
40658-1 |
More Info
|
Lorediplon |
A ligand for α1 subunit-containing GABAA receptors; inhibits spontan… |
10 mg |
23868-10 |
More Info
|
Lorediplon |
A ligand for α1 subunit-containing GABAA receptors; inhibits spontan… |
25 mg |
23868-25 |
More Info
|
Lorediplon |
A ligand for α1 subunit-containing GABAA receptors; inhibits spontan… |
5 mg |
23868-5 |
More Info
|
Lorediplon |
A ligand for α1 subunit-containing GABAA receptors; inhibits spontan… |
50 mg |
23868-50 |
More Info
|
Lorglumide (sodium salt) |
A nonpeptidic antagonist of CCK1 (IC50 = 50 nM) that is 60-fold less effec… |
10 mg |
17555-10 |
More Info
|
Lorglumide (sodium salt) |
A nonpeptidic antagonist of CCK1 (IC50 = 50 nM) that is 60-fold less effec… |
25 mg |
17555-25 |
More Info
|
Lorglumide (sodium salt) |
A nonpeptidic antagonist of CCK1 (IC50 = 50 nM) that is 60-fold less effec… |
5 mg |
17555-5 |
More Info
|
Lorglumide (sodium salt) |
A nonpeptidic antagonist of CCK1 (IC50 = 50 nM) that is 60-fold less effec… |
50 mg |
17555-50 |
More Info
|
Lormetazepam |
An analytical reference standard categorized as a benzodiazepine; an activ… |
1 mg |
21989-1 |
More Info
|
Lormetazepam |
An analytical reference standard categorized as a benzodiazepine; an activ… |
10 mg |
21989-10 |
More Info
|
L-Ornithine (hydrochloride) |
An active metabolite of L-arginine and a non-proteinogenic amino acid; for… |
100 g |
30779-100 |
More Info
|
L-Ornithine (hydrochloride) |
An active metabolite of L-arginine and a non-proteinogenic amino acid; for… |
250 g |
30779-250 |
More Info
|
L-Ornithine (hydrochloride) |
An active metabolite of L-arginine and a non-proteinogenic amino acid; for… |
50 g |
30779-50 |
More Info
|
L-Ornithine (hydrochloride) |
An active metabolite of L-arginine and a non-proteinogenic amino acid; for… |
500 g |
30779-500 |
More Info
|
L-Ornithine lactam (hydrochloride) |
A synthetic intermediate |
1 g |
31683-1 |
More Info
|
L-Ornithine lactam (hydrochloride) |
A synthetic intermediate |
250 mg |
31683-250 |
More Info
|
L-Ornithine lactam (hydrochloride) |
A synthetic intermediate |
500 mg |
31683-500 |
More Info
|
Lornoxicam |
A COX inhibitor and NSAID; inhibits TXB2 production from arachidonic acid… |
100 mg |
70220-100 |
More Info
|
Lornoxicam |
A COX inhibitor and NSAID; inhibits TXB2 production from arachidonic acid… |
250 mg |
70220-250 |
More Info
|
Lornoxicam |
A COX inhibitor and NSAID; inhibits TXB2 production from arachidonic acid… |
50 mg |
70220-50 |
More Info
|
Lornoxicam |
A COX inhibitor and NSAID; inhibits TXB2 production from arachidonic acid… |
500 mg |
70220-500 |
More Info
|
Lornoxicam-d4 |
An internal standard for the quantification of lornoxicam by GC- or LC-MS |
1 mg |
33275-1 |
More Info
|
Lornoxicam-d4 |
An internal standard for the quantification of lornoxicam by GC- or LC-MS |
10 mg |
33275-10 |
More Info
|
Lornoxicam-d4 |
An internal standard for the quantification of lornoxicam by GC- or LC-MS |
5 mg |
33275-5 |
More Info
|
Losartan Azide |
A potential impurity in commercial preparations of losartan |
1 mg |
37387-1 |
More Info
|
Losartan Azide |
A potential impurity in commercial preparations of losartan |
250 µg |
37387-250 |
More Info
|
Losartan Azide |
A potential impurity in commercial preparations of losartan |
5 mg |
37387-5 |
More Info
|
Losartan Azide |
A potential impurity in commercial preparations of losartan |
500 µg |
37387-500 |
More Info
|
Losartan Carboxaldehyde |
An active metabolite of losartan; inhibits arachidonic acid-induced platel… |
1 mg |
18855-1 |
More Info
|
Losartan Carboxaldehyde |
An active metabolite of losartan; inhibits arachidonic acid-induced platel… |
10 mg |
18855-10 |
More Info
|
Losartan Carboxaldehyde |
An active metabolite of losartan; inhibits arachidonic acid-induced platel… |
5 mg |
18855-5 |
More Info
|
Losartan Carboxylic Acid |
An AT1b receptor antagonist and active metabolite of losartan; an antagoni… |
1 mg |
15957-1 |
More Info
|
Losartan Carboxylic Acid |
An AT1b receptor antagonist and active metabolite of losartan; an antagoni… |
10 mg |
15957-10 |
More Info
|
Losartan Carboxylic Acid |
An AT1b receptor antagonist and active metabolite of losartan; an antagoni… |
5 mg |
15957-5 |
More Info
|
Losartan Carboxylic Acid |
An AT1b receptor antagonist and active metabolite of losartan; an antagoni… |
50 mg |
15957-50 |
More Info
|
Losartan-d4 |
An internal standard for the quantification of losartan (potassium salt) b… |
1 mg |
22567-1 |
More Info
|
Losartan-d4 |
An internal standard for the quantification of losartan (potassium salt) b… |
500 µg |
22567-500 |
More Info
|
Losartan (potassium salt) |
An AT1b antagonist (IC50 = 2.2 nM in COS-7 cells expressing the rat recept… |
10 mg |
10006594-10 |
More Info
|
Losartan (potassium salt) |
An AT1b antagonist (IC50 = 2.2 nM in COS-7 cells expressing the rat recept… |
100 mg |
10006594-100 |
More Info
|
Losartan (potassium salt) |
An AT1b antagonist (IC50 = 2.2 nM in COS-7 cells expressing the rat recept… |
50 mg |
10006594-50 |
More Info
|
Losartan (potassium salt) |
An AT1b antagonist (IC50 = 2.2 nM in COS-7 cells expressing the rat recept… |
500 mg |
10006594-500 |
More Info
|
Loteprednol etabonate |
A glucocorticoid receptor agonist with an affinity 4.3 times that of dexam… |
10 mg |
23305-10 |
More Info
|
Loteprednol etabonate |
A glucocorticoid receptor agonist with an affinity 4.3 times that of dexam… |
25 mg |
23305-25 |
More Info
|